It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Children with chronic kidney disease suffer from excessive cardiovascular mortality and early alterations of the cardiovascular system. Tissue doppler imaging is a validated echocardiographic tool to assess early systolic and diastolic cardiac dysfunction. We hypothesized that tissue Doppler velocities would reveal reduced cardiac function in children with chronic kidney disease compared to healthy children. A standardized echocardiographic exam was performed in 128 patients of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study aged 6–17 years with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73 m2. Tissue Doppler measurements included early (E’) and late (A’) diastolic and systolic (S’) velocity at the mitral and septal annulus of the left ventricle. Measured values were normalized to z-scores using published reference data. Predictors of E’/A’, E/E’, S’ and left ventricular mass index (LVMI) were assessed by multiple linear regression analyses. Tissue Doppler E’ was reduced and tissue Doppler A’ increased, resulting in a reduced tissue Doppler E’/A’ ratio (z-score −0.14, p < 0.0001) indicating reduced diastolic function compared to healthy children. Reduced tissue Doppler E’/A’ Z-Scores were independently associated with lower eGFR (p = 0.002) and increased systolic blood pressure (p = 0.02). While E/E’ Z-Scores were increased (Z-score 0.57, p < 0.0001), patients treated with pharmacological RAS blockade but not with other antihypertensive treatments had significantly lower E/E’ and higher E’/A’ Z-Scores. Systolic tissue Doppler velocities were significantly decreased (Z-score −0.24, p = 0.001) and inversely correlated with E/E’ Z-Scores (r = −0.41, p < 0.0001). LVMI was not associated with systolic or diastolic tissue Doppler velocities. Concentric left ventricular hypertrophy showed a tendency to lower S’ in multivariate analysis (p = 0.13) but no association to diastolic function. Concentric left ventricular geometry was significantly associated with lower midwall fractional shortening. In summary, systolic and diastolic function assessed by tissue Doppler is impaired. eGFR, systolic blood pressure and the type of antihypertensive medications are significant predictors of diastolic function in children with CKD. Left ventricular morphology is largely independent of tissue Doppler velocities. Tissue Doppler velocities provide sensitive information about early left ventricular dysfunction in this population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany; 4C Study Consortium, Heidelberg, Germany
2 Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany
3 Division of Pediatric Cardiology, Cukurova University, Adana, Turkey; 4C Study Consortium, Heidelberg, Germany
4 Department of Pediatric Nephrology, Rheumatology and Dermatology, Hospices Civils de Lyon, Lyon, France; 4C Study Consortium, Heidelberg, Germany
5 Service de Pharmacotoxicologie, Centre d’Investigation Clinique, 1407 Inserm, UMR 5558, LBBE, CNRS Lyon, Université de Lyon and Hospices Civils de Lyon, Lyon, France
6 Nephrology and Dialysis Unit, Department of Pediatrics, Azienda Ospedaliero Universitaria Sant Orsola-Malpighi, Bologna, Italy; 4C Study Consortium, Heidelberg, Germany
7 Department of Pediatric Nephrology, Istituto Giannina Gaslini, Genova, Italy; 4C Study Consortium, Heidelberg, Germany
8 Pediatric Nephrology Unit, Department of Pediatrics, Bordeaux University Hospital, Bordeaux, France; 4C Study Consortium, Heidelberg, Germany
9 Department of Nephrology and Urology, Bambino Gesù Pediatric Hospital, Rome, Italy; 4C Study Consortium, Heidelberg, Germany
10 Department of Cardiology, Bambino Gesù Pediatric Hospital, Rome, Italy; 4C Study Consortium, Heidelberg, Germany
11 University Childrens’ and Adolescents’ Hospital Cologne, Cologne, Germany; 4C Study Consortium, Heidelberg, Germany
12 Pediatric Nephrology Unit, Hautepierre University Hospital, Strasbourg, France; 4C Study Consortium, Heidelberg, Germany
13 Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione Osp Maggiore Policlinico, Milan, Italy; 4C Study Consortium, Heidelberg, Germany
14 Pediatric Nephrology, Dialysis and Transplant Unit, Department of Womens and Childrens Health, University Hospital of Padova, Padua, Italy; 4C Study Consortium, Heidelberg, Germany
15 Department of General Pediatrics, Adolescent Medicine and Neonatology, Center for Pediatrics, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg im Breisgau, Germany; 4C Study Consortium, Heidelberg, Germany
16 Center for Pediatrics, Vilnius University, Vilnius, Lithuania; 4C Study Consortium, Heidelberg, Germany
17 Department of Pediatric and Congenital Cardiology, Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany
18 Division of Pediatric Nephrology, Charite Children’s Hospital, Berlin, Germany; 4C Study Consortium, Heidelberg, Germany